Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Total 13F shares
-
26,888,544
-
Share change
-
+26,888,544
-
Total reported value
-
$483,990,454
-
Price per share
-
$18.00
-
Number of holders
-
60
-
Value change
-
+$483,989,851
-
Number of buys
-
60
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2020
As of 31 Mar 2020,
Beam Therapeutics Inc. - COMMON STOCK (BEAM) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,888,544 shares.
The largest 10 holders included
FMR LLC, Redmile Group, LLC, Temasek Holdings (Private) Ltd, HILLHOUSE CAPITAL ADVISORS, LTD., FIL Ltd, BlackRock Inc., SC CHINA HOLDING Ltd, Cormorant Asset Management, LP, Alphabet Inc., and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.